Medical Device Manufacturer Merit Medical Systems Schedules Q3 Earnings Release

Merit Medical Systems will release its third quarter 2026 financial results on October 29, 2026, following market close, with an accompanying investor conference call scheduled for later that day. The medical device company, which develops and manufactures interventional and diagnostic equipment for cardiology, radiology, oncology, and other medical specialties, serves customers globally through approximately 900 sales and clinical support personnel. A live webcast and slide presentation will be made available to investors during the announcement.

Merit Medical Systems, headquartered in South Jordan, Utah, operates as a multinational developer of specialized medical equipment serving healthcare providers across multiple clinical disciplines. The company's portfolio encompasses devices designed for minimally invasive procedures in cardiac care, imaging diagnostics, cancer treatment, intensive care settings, and gastrointestinal procedures. With approximately 7,500 employees globally and a substantial clinical and sales infrastructure of roughly 900 professionals, Merit maintains significant international presence and distribution networks.

The upcoming earnings announcement will provide investors and analysts with performance metrics reflecting the company's operational results during the third quarter of 2026. Merit's investor communication strategy includes both traditional conference call access and digital webcast options, enabling broad participation from financial stakeholders and market observers interested in the medical device sector's performance trajectory.